Ecolab Inc. (NYSE:ECL) is included among the many 14 Greatest Dividend Aristocrats to Put money into Heading into 2026.
On December 18, Citi analyst Patrick Cunningham lowered the worth goal on Ecolab Inc. (NYSE:ECL) to $315 from $323 and maintained a Purchase ranking. The replace adopted revisions to estimates and targets throughout the chemical substances group as a part of Citi’s 2026 outlook. Citi stated it’s turning extra cautious on polyethylene producers. On the similar time, the agency is extra constructive on lithium fundamentals heading into subsequent 12 months.
In different information, on December 16, Ecolab Inc. (NYSE:ECL) closed its beforehand introduced acquisition of Ovivo’s electronics enterprise. The unit is a fast-growing world supplier of ultrapure water applied sciences utilized in semiconductor manufacturing. The deal expands Ecolab’s attain throughout the bogus intelligence worth chain. That features all the things from chip manufacturing to information facilities.
Administration stated the transaction greater than doubles the dimensions of its world high-tech progress engine and positions the corporate as a transparent chief in these markets. By combining Ovivo Electronics’ ultrapure water methods with Ecolab’s world water, digital, and repair capabilities, the corporate plans to ship crucial round water administration options. The main focus is on lowering water use within the water-intensive semiconductor business.
Ecolab Inc. (NYSE:ECL) is a world sustainability chief that gives water, hygiene, and an infection prevention options and companies geared toward defending folks and important pure assets.
Whereas we acknowledge the potential of ECL as an funding, we imagine sure AI shares provide better upside potential and carry much less draw back threat. In case you’re on the lookout for an especially undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.
READ NEXT: 14 Greatest Pharma Dividend Shares to Purchase in 2026 and 15 World Dividend Shares to Diversify Your Portfolio.
Disclosure: None.